OPKO Health Operating Income 2010-2023 | OPK

OPKO Health operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
OPKO Health Annual Operating Income
(Millions of US $)
2023 $-157
2022 $-226
2021 $19
2020 $58
2019 $-274
2018 $-171
2017 $-276
2016 $-97
2015 $-98
2014 $-146
2013 $-80
2012 $-37
2011 $-23
2010 $-11
2009 $-22
OPKO Health Quarterly Operating Income
(Millions of US $)
2023-12-31 $-69
2023-09-30 $-64
2023-06-30 $7
2023-03-31 $-31
2022-12-31 $-55
2022-09-30 $-88
2022-06-30 $-11
2022-03-31 $-72
2021-12-31 $-63
2021-09-30 $38
2021-06-30 $6
2021-03-31 $38
2020-12-31 $49
2020-09-30 $22
2020-06-30 $27
2020-03-31 $-41
2019-12-31 $-112
2019-09-30 $-39
2019-06-30 $-47
2019-03-31 $-75
2018-12-31 $-90
2018-09-30 $-33
2018-06-30 $-5
2018-03-31 $-43
2017-12-31 $-158
2017-09-30 $-48
2017-06-30 $-26
2017-03-31 $-45
2016-12-31 $-74
2016-09-30 $-24
2016-06-30 $28
2016-03-31 $-28
2015-12-31 $-8
2015-09-30 $-8
2015-06-30 $-25
2015-03-31 $-57
2014-12-31 $-32
2014-09-30 $-48
2014-06-30 $-35
2014-03-31 $-30
2013-12-31 $-36
2013-09-30 $-19
2013-06-30 $-18
2013-03-31 $-7
2012-12-31 $-10
2012-09-30 $-9
2012-06-30 $-9
2012-03-31 $-9
2011-12-31 $-8
2011-09-30 $-6
2011-06-30 $-5
2011-03-31 $-4
2010-12-31 $3
2010-09-30 $-4
2010-06-30 $-6
2010-03-31 $-4
2009-12-31 $-2
2009-09-30 $-6
2009-06-30 $-5
2009-03-31 $-9
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.871B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $208.893B 25.41
Intuitive Surgical (ISRG) United States $132.624B 82.78
Edwards Lifesciences (EW) United States $52.512B 34.76
DexCom (DXCM) United States $51.605B 88.65
IQVIA Holdings (IQV) United States $41.246B 24.46
IDEXX Laboratories (IDXX) United States $39.720B 47.49
Alcon (ALC) Switzerland $38.955B 28.73
STERIS (STE) Ireland $19.787B 23.42
Waters (WAT) United States $18.041B 25.89
Hologic (HOLX) United States $17.586B 19.41
SONOVA HOLDING (SONVY) Switzerland $16.281B 0.00
ShockWave Medical (SWAV) United States $12.247B 84.62
Fresenius Medical Care AG KGaA (FMS) Germany $11.132B 13.75
Sysmex ADR (SSMXY) Japan $9.874B 30.97
Teleflex (TFX) United States $9.811B 15.41
Penumbra (PEN) United States $8.077B 99.85
Masimo (MASI) United States $7.229B 40.54
Globus Medical (GMED) United States $6.931B 21.97
Glaukos (GKOS) United States $4.863B 0.00
Integer Holdings (ITGR) United States $3.971B 25.38
TransMedics (TMDX) United States $2.874B 0.00
LivaNova (LIVN) United Kingdom $2.799B 18.46
PROCEPT BioRobotics (PRCT) United States $2.639B 0.00
Elekta AB (EKTAY) Sweden $2.635B 18.08
Integra LifeSciences Holdings (IART) United States $2.511B 10.30
Nihon Kohden (NHNKY) Japan $2.303B 19.48
Inari Medical (NARI) United States $2.243B 387.00
Tandem Diabetes Care (TNDM) United States $2.050B 0.00
RxSight (RXST) United States $1.954B 0.00
Alphatec Holdings (ATEC) United States $1.726B 0.00
Veracyte (VCYT) United States $1.416B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.99
Artivion (AORT) United States $0.822B 94.95
Paragon 28 (FNA) United States $0.807B 0.00
OrthoPediatrics (KIDS) United States $0.711B 0.00
Treace Medical Concepts (TMCI) United States $0.704B 0.00
Silk Road Medical (SILK) United States $0.684B 0.00
SiBone (SIBN) United States $0.625B 0.00
Mesa Laboratories (MLAB) United States $0.546B 18.52
IRadimed (IRMD) United States $0.513B 29.76
ORTHOFIX MEDICAL INC (OFIX) United States $0.486B 0.00
Nevro (NVRO) United States $0.451B 0.00
Pulse Biosciences (PLSE) United States $0.413B 0.00
Pacific Biosciences Of California (PACB) United States $0.375B 0.00
NeuroPace (NPCE) United States $0.361B 0.00
CVRx (CVRX) United States $0.339B 0.00
Tactile Systems Technology (TCMD) United States $0.336B 11.33
AxoGen (AXGN) United States $0.303B 0.00
EDAP TMS S.A (EDAP) France $0.273B 0.00
Sight Sciences (SGHT) United States $0.267B 0.00
AngioDynamics (ANGO) United States $0.254B 0.00
Accuray (ARAY) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.187B 0.00
908 Devices (MASS) United States $0.184B 0.00
Semler Scientific (SMLR) United States $0.180B 9.72
Atossa Genetics (ATOS) United States $0.169B 0.00
Inogen (INGN) United States $0.162B 0.00
ClearPoint Neuro (CLPT) United States $0.150B 0.00
Neuronetics (STIM) United States $0.119B 0.00
Delcath Systems (DCTH) United States $0.114B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
Envoy Medical (COCH) United States $0.108B 0.00
KORU Medical Systems (KRMD) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
Vasomedical (VASO) United States $0.055B 9.83
Autonomix Medical (AMIX) United States $0.054B 0.00
Sensus Healthcare (SRTS) United States $0.053B 108.33
InspireMD (NSPR) Israel $0.052B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
LENSAR (LNSR) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.018B 0.00
T2 Biosystems (TTOO) United States $0.016B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Accelerate Diagnostics (AXDX) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00